Loading clinical trials...
Loading clinical trials...
This is a phase 4, multicenter, randomized, non-therapeutic interventional trial in subjects with psoriasis looking for the prevalence of psoriatic arthritis. Subjects will be seen and evaluated by a dermatologist at visit 1 and by a rheumatologist at visit 2. A subset of subjects will then go on to visit 3 for imaging procedures (x-ray, MRI, and ultrasound).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Modern Research Assoc. PLLC
Dallas, Texas, United States
Rheumatology Practive of Scott Zashin, MD
Dallas, Texas, United States
Center for Clinical Studies Ltd LLP
Houston, Texas, United States
Rheumatology Associates of Houston
Houston, Texas, United States
Center for Clinical Studies LTD LLP
Webster, Texas, United States
Dermatology Associates
Seattle, Washington, United States
Universitair Ziekenhuis Gent
Ghent, Belgium, Belgium
Algemeen Ziekenhuis St. Jan
Bruges, Belgium
Kirk Barber Research
Calgary, Alberta, Canada
Stratica Medical
Edmonton, Alberta, Canada
Start Date
August 1, 2010
Primary Completion Date
July 1, 2011
Completion Date
July 1, 2011
Last Updated
June 21, 2012
1,013
ACTUAL participants
lab draws and imaging
PROCEDURE
Lead Sponsor
Pfizer
NCT07295509
NCT07449234
NCT07116967
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions